childhood obesity drug trials

childhood obesity drug trials

Why 73% Drop With Semaglutide Won't Save Kids

Semaglutide’s 73% reduction in extreme BMI is impressive, but regulatory hurdles, cost barriers and long-term safety concerns mean it alone won’t solve childhood obesity. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health